Kim-Schulze, S., Jagannath, S., Gnjatic, S., Chari, A., Parekh, S., Osman, K., . . . Catamero, D. Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationKim-Schulze, Seunghee, et al. Phase 1 Study Combining Elotuzumab with Autologous Stem Cell Transplant and Lenalidomide for Multiple Myeloma. BMJ Publishing Group.
MLA (9th ed.) CitationKim-Schulze, Seunghee, et al. Phase 1 Study Combining Elotuzumab with Autologous Stem Cell Transplant and Lenalidomide for Multiple Myeloma. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.